Get the Stockscreener App
4.69
3.30%
-0.16
After Hours:
4.69
Endra Life Sciences Inc stock is traded at $4.69, with a volume of 24,023.
It is down -3.30% in the last 24 hours and down -7.13% over the past month.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
See More
Previous Close:
$4.85
Open:
$4.848
24h Volume:
24,023
Relative Volume:
1.06
Market Cap:
$8.67M
Revenue:
-
Net Income/Loss:
$-7.30M
P/E Ratio:
-0.5756
EPS:
-8.148
Net Cash Flow:
$-8.01M
1W Performance:
+6.11%
1M Performance:
-7.13%
6M Performance:
-5.06%
1Y Performance:
+38.35%
1-Day Range:
$4.34
$4.928
1-Week Range:
$4.15
$5.00
52-Week Range:
$2.96
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.69 | 8.97M | 0 | -7.30M | -8.01M | -8.148 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Endra Life Sciences Inc Stock (NDRA) Latest News
NDRA Technical Analysis & Stock Price Forecast - Intellectia AI
ENDRA Life Sciences (NDRA) Jumps 11% as Momentum Builds Toward Key ResistanceSystematic Flow - newsline.com
NDRA | ENDRA Life Sciences Inc. Insider Trading - Quiver Quantitative
ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic - openPR.com
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Amid No RevenueLong-Term Guidance - newsline.com
NDRA Q1 2026 Earnings: EPS Misses Estimates Amid Continued Development Stage OperationsEarnings Volatility Report - newsline.com
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
NDRA Maintained by Ascendiant Capital -- Price Target Lowered to $25 - GuruFocus
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know - Benzinga
ENDRA Life Sciences (NDRA) Holds Steady Near Support as Micro-Cap Biotech Awaits CatalystsDealer Positioning - The Legal Advocate
ENDRA Life Sciences Withdraws Filing for Securities Offering - Moomoo
ENDRA Life Sciences Inc. Announces Private Placement Securities Purchase Agreement and Issuance of Warrants – May 2026 - Minichart
ENDRA Life Sciences Announces Strategic Private Placement Financing - TipRanks
ENDRA Life Sciences Raises $3.8 Million in Private Placement; Sets Cash Safeguards in Side Letter - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) raises $3.8M to bolster equity for Nasdaq - Stock Titan
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW! - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS - openPR.com
ENDRA Life Sciences Inc. announced that it expects to receive $3.800003 million in funding - marketscreener.com
[RW] ENDRA Life Sciences Inc. SEC Filing - Stock Titan
ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573The Legal Advocate - The Legal Advocate
NDRA Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Stage ContinuesEarnings Manipulation Risk - Newser
ENDRA Life Sciences Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Continues DevelopmentUpward Estimate Revision - Newser
ENDRA Life Sciences (NDRA) Shows Modest Gains, Testing Resistance at $5.73Option Breadth - newsline.com
ENDRA Life Sciences Q1 2026 Earnings: EPS Misses Estimates as Development ContinuesQuarterly Financial Update - The Legal Advocate
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - The Chronicle-Journal
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TipRanks
NDRA Strengthens Clinical Foundation for TAEUS Liver Technology - GuruFocus
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) faces Nasdaq equity notice after Q1 loss - Stock Titan
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ENDRA Life (NDRA) Q4 2025 Results Miss Estimates — EPS $-3.26 vs $-1.25Expert Stock Picks - Newser
NDRA Q1'26 Earnings: EPS estimate is (1.23) USD - TradingView
Endra Life Sciences (NDRA) Achieves Promising Results with TAEUS Liver - GuruFocus
Endra Life Sciences reports multi-site validation of TAEUS Liver device - TipRanks
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accu - PharmiWeb.com
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - BioSpace
ENDRA reports multi-site validation results for liver imaging device - Investing.com UK
ENDRA reports multi-site validation results for liver imaging device By Investing.com - Investing.com Australia
Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
TradingKey - TradingKey
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play - openPR.com
Is ENDRA Life (NDRA) stock suitable for your portfolio? (Nudges Down) 2026-04-27Senior Analyst Forecasts - Newser
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):